Catalyst Pharmaceuticals Revenue 2006-2019 | CPRX

Catalyst Pharmaceuticals revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Catalyst Pharmaceuticals Annual Revenue
(Millions of US $)
2018 $1
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $0
2009 $
2008 $
2007 $
2006 $
2005 $
Catalyst Pharmaceuticals Quarterly Revenue
(Millions of US $)
Q3 2019 $31
Q2 2019 $29
Q1 2019 $12
Q4 2018
Q3 2018
Q2 2018
Q1 2018
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2013
Q4 2012
Q3 2012
Q2 2012
Q1 2012
Q4 2011
Q3 2011
Q2 2011
Q1 2011
Q4 2010
Q3 2010
Q2 2010
Q1 2010
Q4 2009
Q3 2009
Q2 2009
Q1 2009
Q4 2008
Q3 2008
Q2 2008
Q1 2008
Q4 2007
Q3 2007
Q2 2007
Q1 2007
Q4 2006
Q3 2006
Q2 2006
Q1 2006
Q3 2005
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.433B $0.001B
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), anti-MuSK antibody positive myasthenia gravis (MuSK-MG), congenital myasthenic syndromes (CMS), and spinal muscular atrophy (SMA) Type 3.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.891B 39.41
Takeda Pharmaceutical (TAK) Japan $62.405B 9.86
Astellas Pharma (ALPMY) Japan $32.771B 16.37
Eisai (ESALY) Japan $21.953B 42.32
Merck (MKGAF) Germany $16.705B 22.80
Grifols, S.A (GRFS) Spain $15.965B 20.92
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Neurocrine Biosciences (NBIX) United States $9.410B 444.24
Catalent (CTLT) United States $9.008B 36.65
Ionis Pharmaceuticals (IONS) United States $8.496B 17.21
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.435B 10.77
IPSEN SA ADR (IPSEY) France $7.632B 0.00
STADA ARZNEIMI (STDAF) Germany $5.991B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.540B 0.00
Hypermarcas (HYPMY) Brazil $5.336B 16.23
Arrowhead Pharmaceuticals (ARWR) United States $4.423B 66.97
Evotec AG (EVTCY) Germany $4.301B 69.51
United Therapeutics (UTHR) United States $3.988B 0.00
FibroGen (FGEN) United States $3.853B 113.23
Nektar Therapeutics (NKTR) United States $3.830B 0.00
Sage Therapeutics (SAGE) United States $3.651B 0.00
PTC Therapeutics (PTCT) United States $3.287B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.239B 11.92
Zogenix (ZGNX) United States $2.404B 0.00
ChemoCentryx (CCXI) United States $2.365B 0.00
Tilray (TLRY) Canada $2.128B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.128B 0.00
Heron Therapeutics (HRTX) United States $2.107B 0.00
Xencor (XNCR) United States $2.043B 62.09
Ironwood Pharmaceuticals (IRWD) United States $2.012B 64.15
Pacira Pharmaceuticals (PCRX) United States $1.834B 54.25
USANA Health Sciences (USNA) United States $1.659B 17.70
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.522B 10.39
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
Corcept Therapeutics (CORT) United States $1.501B 18.24
Endo (ENDP) Ireland $1.496B 2.75
Theravance Biopharma (TBPH) Cayman Islands $1.468B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.109B 25.23
Karyopharm Therapeutics (KPTI) United States $1.089B 0.00
Portola Pharmaceuticals (PTLA) United States $1.070B 0.00
Aerie Pharmaceuticals (AERI) United States $1.045B 0.00
Dermira (DERM) United States $1.023B 0.00
Akebia Therapeutics (AKBA) United States $1.019B 0.00
Radius Health (RDUS) United States $0.873B 0.00
ImmunoGen (IMGN) United States $0.734B 0.00
Collegium Pharmaceutical (COLL) United States $0.710B 0.00
TherapeuticsMD (TXMD) United States $0.694B 0.00
Flexion Therapeutics (FLXN) United States $0.687B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.553B 0.00
Molecular Templates (MTEM) United States $0.531B 0.00
Translate Bio (TBIO) United States $0.522B 0.00
Ardelyx (ARDX) United States $0.475B 0.00
Organogenesis Holdings (ORGO) United States $0.470B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.454B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.445B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.444B 0.00
Innate Pharma SA (IPHYF) France $0.432B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.431B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.427B 18.40
Siga Technologies (SIGA) United States $0.422B 9.65
DURECT (DRRX) United States $0.404B 0.00
Lannett Co Inc (LCI) United States $0.395B 4.60
OptiNose (OPTN) United States $0.371B 0.00
Calithera Biosciences (CALA) United States $0.371B 0.00
Harpoon Therapeutics (HARP) United States $0.369B 0.00
Recro Pharma (REPH) United States $0.369B 0.00
Rafael Holdings (RFL) United States $0.356B 0.00
Indivior (INVVY) United States $0.339B 1.23
Spectrum Pharmaceuticals (SPPI) United States $0.324B 0.00
KalVista Pharmaceuticals (KALV) United States $0.322B 0.00
Concert Pharmaceuticals (CNCE) United States $0.304B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.282B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.261B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.246B 0.00
MEI Pharma (MEIP) United States $0.239B 0.00
Ocular Therapeutix (OCUL) United States $0.225B 0.00
IMV INC (IMV) Canada $0.222B 0.00
Jounce Therapeutics (JNCE) United States $0.217B 2.90
La Jolla Pharmaceutical (LJPC) United States $0.209B 0.00
Nature's Sunshine Products (NATR) United States $0.190B 32.83
Taiwan Liposome (TLC) Taiwan $0.171B 0.00
Xeris Pharmaceuticals (XERS) United States $0.163B 0.00
CannTrust Holdings (CTST) Canada $0.157B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.143B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.136B 0.00
Redhill Biopharma (RDHL) Israel $0.130B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.128B 0.00
CV Sciences (CVSI) United States $0.117B 0.00
Otonomy (OTIC) United States $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.107B 0.00
PolarityTE (PTE) United States $0.106B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.104B 0.00
Aquestive Therapeutics (AQST) United States $0.099B 0.00
Champions Oncology (CSBR) United States $0.099B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.094B 0.00
Neos Therapeutics (NEOS) United States $0.087B 0.00
Infinity Pharmaceuticals (INFI) United States $0.087B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.076B 22.82
RENEURON GP (RNUGF) United Kingdom $0.074B 0.00
CTI BioPharma (CTIC) United States $0.073B 0.00
AgeX Therapeutics (AGE) United States $0.070B 0.00
Aclaris Therapeutics (ACRS) United States $0.066B 0.00
Natural Alternatives (NAII) United States $0.066B 16.49
Entasis Therapeutics Holdings (ETTX) United States $0.066B 0.00
Nivalis Therapeutics (ALPN) United States $0.060B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.00
IsoRay (ISR) United States $0.057B 0.00
Onconova Therapeutics (ONTX) United States $0.057B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Forward Pharma (FWP) Denmark $0.047B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.045B 0.00
Jaguar Animal Health (JAGX) United States $0.041B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Biomerica (BMRA) United States $0.030B 0.00
India Globalization Capital (IGC) United States $0.027B 0.00
VAXART, INC (VXRT) United States $0.025B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.018B 0.00
Novan (NOVN) United States $0.018B 0.00
Shineco (TYHT) China $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Lipocine (LPCN) United States $0.013B 0.00
Flex Pharma (SLRX) United States $0.013B 0.00
Vical (BBI) United States $0.012B 0.00
Heat Biologics (HTBX) United States $0.011B 0.00
Hemispherx BioPharma (AIM) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00